SCHEMBL29316986

SCHEMBL29316986

CC(C)N1CC(N2CCC3(CC2)CN(C2CN(C)C2)C3)C1

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 9/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25855172 0.90 HRH3 (0.45) HRH3
SCHEMBL24185424 0.88 HRH3 (0.34) HRH3
SCHEMBL29316995 0.87 HRH3 (0.37) HRH3
SCHEMBL24185458 0.87 HRH3 (0.40) HRH3
SCHEMBL24266883 0.85 HRH3 (0.35) HRH3
SCHEMBL22565155 0.85 HRH3 (0.43) HRH3
SCHEMBL25855894 0.83 HRH3 (0.40) HRH3
SCHEMBL22565976 0.81 HRH3 (0.40) HRH3
SCHEMBL22565052 0.80 HRH3 (0.34) HRH3
SCHEMBL22565072 0.80 CYP3A4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed